Efficacy of intranasal cetamine for pain reduction in adults in emergency situations: a systematic literature review

Authors

DOI:

https://doi.org/10.29352/mill0218e.36563

Keywords:

ketamine; intranasal ketamine; pain management; emergency medical services

Abstract

Introduction: Pain is one of the most prevalent clinical manifestations in emergency settings. Traditionally, opiates have been widely used to control it, but in recent decades there has been a significant change in analgesic approaches, with growing interest in non-opiate alternatives. These include ketamine, whose pharmacological profile has aroused interest due to its analgesic efficacy, especially in situations of intense acute pain.

Objective To identify the use of intranasal ketamine to reduce pain in adults in emergency situations.

Methods: Systematic literature review, guided by the PI[C]OD search strategy, with extraction of articles supported by Rayyan software. Articles written in English, Portuguese, Spanish and/or French were taken into account, with a time frame between 2018-2023, searched in the PubMed and CINAHL complete databases and on the B-On online platform.

Results: Analysing the evidence from the three studies demonstrated the efficacy of using intranasal ketamine to reduce pain in emergency situations. Intranasal ketamine, when added to nitrous oxide, provided a significant reduction in pain, improved comfort compared to intranasal placebo and had fewer adverse reactions. However, the length of stay in the emergency department for patients receiving ketamine in a pre-hospital setting, as an alternative to morphine or fentanyl, may be less than desirable for adequate clinical monitoring, especially in the treatment of isolated non-cardiorespiratory pain conditions.

Conclusion: The use of intranasal ketamine seems to be effective in controlling acute pain in adults in emergency situations, but more randomised controlled studies are needed to strengthen the evidence found.

Downloads

Download data is not yet available.

References

Andolfatto, G., Innes, K., Dick, W., Jenneson, S., Willman, E., Stenstrom, R., Zed, P. J., & Benoit, G. (2019). Prehospital analgesia with intranasal ketamine (PAIN-K): A randomized double-blind trial in adults. Annals of Emergency Medicine, 74:241–50. https://doi.org/10.1016/j.annemergmed.2019.01.048

Baratloo, A., Mirbaha, S., Delavar Kasmaei, H., Payandemehr, P., Elmaraezy, A., & Negida, A. (2017). Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study. The Korean Journal of Pain, 30(3), 176. https://doi.org/10.3344/kjp.2017.30.3.176

Baekgaard, J. S., Eskesen, T. G., Sillesen, M., Rasmussen, L. S., & Steinmetz, J. (2019). Ketamine as a Rapid Sequence Induction Agent in the Trauma Population: A Systematic Review. Anesthesia and Analgesia, 128(3), 504–510. https://doi.org/10.1213/ANE.0000000000003568

Cunha, M., & Santos, E. (2021). Revisão sistemática da literatura com meta-análise: um guia prático para iniciantes. Edições Esgotadas.

Donato, H., & Donato, M. (2019). Etapas na Condução de uma Revisão Sistemática. Acta Médica Portuguesa, 32(3), 227. https://doi.org/10.20344/amp.11923

Dove D., Fassassi C., Davis A., Drapkin J., Butt M., Hossain R., Kabariti S., et al. (2021). Comparison of Nebulized Ketamine at Three Different Dosing Regimens for Treating Painful Conditions in the Emergency Department: A Prospective, Randomized, Double-Blind Clinical Trial. https://doi.org/10.1016/j.annemergmed.2021.04.031

Graudins A, Meek R, Egerton-Warburton D, et al. (2015). The PICHFORK (Pain in Children Fentanyl or Ketamine) trial: a randomized controlled trial comparing intranasal ketamine and fentanyl for the relief of moderate to severe pain in children with limb injuries. Ann Emerg Med. 2015;65:248-254.e1. https://doi.org/10.1016/j.annemergmed.2014.09.024

Huge H, Lauchart M, Magerl W, et al. (2012). Effects of low-dose intranasal (S)- ketamine in patients with neuropathic pain. Eur J Pain. 2010, 14, 387-394. https://doi.org/10.1016/j.ejpain.2009.08.002

Jordan Z, Lockwood C, Aromataris E, Munn Z. The updated JBI model for evidence-based healthcare. The Joanna Briggs Institute. 2016. https://doi.org/10.1097/xeb.0000000000000155

Merelman AH, Perlmutter MC, Strayer RJ. (2019). Alternatives to rapid sequence intubation: contemporary airway management with ketamine. West J Emerg Med 2019; 20: 466-471. https://doi.org/10.5811/westjem.2019.4.42753

Miller JP, Schauer SG, Ganem VJ, et al. (2015). Low-dose ketamine vs morphine for acute pain in the ED: a randomized controlled trial. Am J Emerg Med. 2015;33:402-408. https://doi.org/10.1016/j.ajem.2014.12.058

Motov S, Strayer R, Hayes BD, et al. (2018). The treatment of acute pain in the emergency department: a white paper position statement prepared for the American Academy of Emergency Medicine. J Emerg Med. 2018;54:731-736. https://doi.org/10.1016/j.jemermed.2018.01.020

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., McGuinness, L. A., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed.), 372, n71. https://doi.org/10.1136/bmj.n71

Robinson EJ, Watanabe BL, Brown LH. (2020). Ketamine for Prehospital Pain Management Does Not Prolong Emergency Department Length of Stay. Prehosp Emerg Care;25(6):753-760. https://doi.org/10.1080/10903127.2020.1819493

Seak, Y. S., Nor, J., Tuan Kamauzaman, T. H., Arithra, A., & Islam, M. A. (2021). Efficacy and safety of intranasal ketamine for acute pain management in the emergency setting: A systematic review and meta-analysis. Journal of Clinical Medicine, 10(17), 3978. https://doi.org/10.3390/jcm10173978

Sepulveda Ramos, C., Thornburg, M., Long, K., Sharma, K., Roth, J., Lacatusu, D., Whitaker, R., Pacciulli, D., Moredo Loo, S., Manzoor, M., Tsang, Y.-Y., Molenaar, S., Sundar, K., & Jacobs, R. J. (sem data). The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review. Cureus, 14(3), e23647. https://doi.org/10.7759/cureus.23647

Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Systematic reviews of effectiveness (2020). Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. JBI; 2024. Available from: https://synthesismanual.jbi.global. https://doi.org/10.46658/JBIMES-24-03

Villanueva, M. T. (2017). Analgesia: Designing out opioid side effects. Nature Reviews. Drug Discovery, 16(5), 311. https://doi.org/10.1038/nrd.2017.68

Published

2025-06-25

How to Cite

Antunes, M., Gomes, M. F., Matos, M., Vieira, V., & Gama, F. (2025). Efficacy of intranasal cetamine for pain reduction in adults in emergency situations: a systematic literature review . Millenium - Journal of Education, Technologies, and Health, 2(18e), e36563. https://doi.org/10.29352/mill0218e.36563

Issue

Section

Life and Healthcare Sciences